Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Why Don't We All Get… >
Why Don't We All Get Alzheimer's Disease?

Published: August 7, 2013.
By University of California - San Diego
http://www.ucsd.edu

Though one might think the brains of people who develop Alzheimer's disease (AD) possess building blocks of the disease absent in healthy brains, for most sufferers, this is not true. Every human brain contains the ingredients necessary to spark AD, but while an estimated 5 million Americans have AD – a number projected to triple by 2050 – the vast majority of people do not and will not develop the devastating neurological condition.

For researchers like Subhojit Roy, MD, PhD, associate professor in the Departments of Pathology and Neurosciences at the University of California, San Diego School of Medicine, these facts produce a singular question: Why don't we all get Alzheimer's disease?

In a paper published in the August 7 issue of the journal Neuron, Roy and colleagues offer an explanation – a trick of nature that, in most people, maintains critical separation between a protein and an enzyme that, when combined, trigger the progressive cell degeneration and death characteristic of AD.

"It's like physically separating gunpowder and match so that the inevitable explosion is avoided," said principal investigator Roy, a cell biologist and neuropathologist in the Shiley-Marcos Alzheimer's Disease Research Center at UC San Diego. "Knowing how the gunpowder and match are separated may give us new insights into possibly stopping the disease."

The severity of AD is measured in the loss of functioning neurons. In pathological terms, there are two tell-tale signs of AD: clumps of a protein called beta-amyloid "plaques" that accumulate outside neurons and threads or "tangles" of another protein, called tau, found inside neurons. Most neuroscientists believe AD is caused by the accumulating assemblies of beta-amyloid protein triggering a sequence of events that leads to impaired cell function and death. This so-called "amyloid cascade hypothesis" puts beta-amyloid protein at the center of AD pathology.

Creating beta-amyloid requires the convergence of a protein called amyloid precursor protein (APP) and an enzyme that cleaves APP into smaller toxic fragments called beta-secretase or BACE.

"Both of these proteins are highly expressed in the brain," said Roy, "and if they were allowed to combine continuously, we would all have AD."

But that doesn't happen. Using cultured hippocampal neurons and tissue from human and mouse brains, Roy – along with first author Utpal Das, a postdoctoral fellow in Roy's lab, and colleagues – discovered that healthy brain cells largely segregate APP and BACE-1 into distinct compartments as soon as they are manufactured, ensuring the two proteins do not have much contact with each other.

"Nature seems to have come up with an interesting trick to separate co-conspirators," said Roy.

The scientists also found that the conditions promoting greater production of beta-amyloid protein boost the convergence of APP and BACE. Specifically, an increase in neuronal electrical activity – known to increase the production of beta-amyloid – also led to an increase in APP-BACE convergence. Post-mortem examinations of AD patients revealed increased physical proximity of the proteins as well, adding support to the pathophysiological significance of this phenomenon in human disease.

Das said the findings are fundamentally important because they elucidate some of the earliest molecular events triggering AD and show how a healthy brain naturally avoids them. In clinical terms, they point to a possible new avenue for ultimately treating or even preventing the disease.

"An exciting aspect is that we can perhaps screen for molecules that can physically keep APP and BACE-1 apart," said Das. "It's a somewhat unconventional approach."


Show Reference »


Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the ScienceNewsline.
Related »

Beta-Amyloid 
10/8/10 
UT Southwestern Researchers Create Experimental Vaccine Against Alzheimer's
By UT Southwestern Medical Center
DALLAS – Oct. 12, 2010 – Researchers at UT Southwestern Medical Center have created an experimental vaccine against beta-amyloid, the small protein that forms plaques in the brain and …
Alzheimer 
4/11/13 
New Findings on the Brain's Immune Cells During Alzheimer's Disease Progression
By Helmholtz Association of German Research Centres
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one …
Immune 
2/3/14 
Can a Protein Controlling Blood Pressure Enhance Immune Responses And Prevent Alzheimer's?
By Cedars-Sinai Medical Center
LOS ANGELES (EMBARGOED UNTIL 12 NOON EST ON FEB. 3, 2014) – Many people with high blood pressure are familiar with ACE inhibitors, drugs that widen blood vessels by …
Vascular 
12/13/13 
Study Breaks Blood-brain Barriers to Understanding Alzheimer's
By National Institute of Neurological Disorders and Stroke
A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest …
Proteins 
10/24/13 
Study by Researchers at Saarland University Demonstrates Preventive Effect of Sterols in Alzheimer's
By Saarland University
"Plant sterols are present in various combinations in nuts, seeds and plant oils. As plant sterols are the equivalents of animal cholesterol, they can in principal influence metabolic processes, …
Gsap 
9/1/10 
Scientists Identify Protein That Spurs Formation of Alzheimer's Plaques
By Rockefeller University
In Alzheimer's disease, the problem is beta-amyloid, a protein that accumulates in the brain and causes nerve cells to weaken and die. Drugs designed to eliminate plaques made of …
More » 

Most Popular - Medicine »
MARIJUANA »
Casual Marijuana Use Linked to Brain Abnormalities in Students
CHICAGO --- Young adults who used marijuana only recreationally showed significant abnormalities in two key brain regions that are important in emotion and motivation, scientists report. The study was …
TUMORS »
The Immune System's Redesigned Role in Fighting Cancerous Tumors
LOS ANGELES (March 11, 2014) – Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. …
CALORIE »
The Surprising Consequences of Banning Chocolate Milk
MEASLES »
Researchers Develop a New Drug to Combat the Measles
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says.
OBESITY »
Researchers: Obesity Can Amplify Bone And Muscle Loss
ScienceNewsline  |  About  |  Privacy Policy  |  Feedback  |  Mobile  |  Japanese
The selection and placement of stories are determined automatically by a computer program. All contents are copyright of their owners except U.S. Government works. U.S. Government works are assumed to be in the public domain unless otherwise noted. Everything else copyright ScienceNewsline.